Pneumococcal Conjugate Vaccine

Resource Center

Q&As

Research Summaries

Respiratory Diseases Roundup

Respiratory Diseases Roundup

Emerging Data on Durability, Immunogenicity, and Patient Trust

01/05/2026

Kate Young

New data describe durability of XBB.1.5 vaccine antibodies, platform-specific vaccine immunogenicity, CDC safety trust, and 2025 US uptake barriers.

01/05/2026

Research Summary

Research Summary

CDC, AAP Release 2022-2023 Immunization Schedules for Children, Adolescents

04/04/2023

Jessica Ganga

The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.

04/04/2023

Vaccine Recommendations

ACIP Releases 2023 Adult Immunization Schedule

02/13/2023

The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.

02/13/2023

Immunization

ACIP Updates Adult Vaccine Schedule

02/22/2022

The CDC Advisory Committee on Immunization Practices recently updated their vaccine recommendations for adults.

02/22/2022

Pneumococcal Conjugate Vaccine

CDC: PCV13 No Longer Recommended for All Older Adults

11/22/2019

The Centers for Disease Control and Prevention (CDC) have released updated recommendations regarding the use of 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide...

11/22/2019

April 2026

Current Issue

April 2026